{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:32:06Z","timestamp":1793971926049,"version":"4.8.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2026J001586"],"award-info":[{"award-number":["2026J001586"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025J01773"],"award-info":[{"award-number":["2025J01773"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejphar.2026.179343","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:37:09Z","timestamp":1789627029000},"page":"179343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Farnesol mitigates post-infarction ventricular remodeling via pharmacological modulation of the SPHK2\/S1P\/SMAD3 axis"],"prefix":"10.1016","volume":"1038","author":[{"given":"Chanyuan","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanming","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beilei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9741-1687","authenticated-orcid":false,"given":"Yukun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.ejphar.2026.179343_bib1","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1093\/eurheartj\/ehi419","article-title":"Infarct-related artery occlusion, tissue markers of ischaemia, and increased apoptosis in the peri-infarct viable myocardium","volume":"26","author":"Abbate","year":"2005","journal-title":"Eur. Heart J."},{"issue":"24","key":"10.1016\/j.ejphar.2026.179343_bib2","doi-asserted-by":"crossref","first-page":"30118","DOI":"10.1007\/s11356-020-09296-w","article-title":"Farnesol attenuates oxidative stress and liver injury and modulates fatty acid synthase and acetyl-CoA carboxylase in high cholesterol-fed rats","volume":"27","author":"Abukhalil","year":"2020","journal-title":"Environ. Sci. Pollut. Control Ser."},{"issue":"2","key":"10.1016\/j.ejphar.2026.179343_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27020811","article-title":"Farnesol, a dietary sesquiterpene, attenuates rotenone-induced dopaminergic neurodegeneration by inhibiting oxidative stress, inflammation, and apoptosis via mediation of cell signaling pathways in rats","volume":"27","author":"Bader Eddin","year":"2026","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ejphar.2026.179343_bib4","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.cmet.2018.11.017","article-title":"Inhibition of mevalonate pathway prevents adipocyte browning in mice and men by affecting protein prenylation","volume":"29","author":"Balaz","year":"2019","journal-title":"Cell Metab."},{"issue":"11","key":"10.1016\/j.ejphar.2026.179343_bib5","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1161\/ATVBAHA.119.313348","article-title":"Force sensing by piezo channels in cardiovascular health and disease","volume":"39","author":"Beech","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.ejphar.2026.179343_bib6","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1161\/CIRCRESAHA.117.312586","article-title":"Mechanisms of cardiac repair and regeneration","volume":"122","author":"Broughton","year":"2018","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.ejphar.2026.179343_bib7","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ahj.2014.06.028","article-title":"Cardiac and vascular effects of fingolimod: mechanistic basis and clinical implications","volume":"168","author":"Camm","year":"2014","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ejphar.2026.179343_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.mucimm.2026.03.004","article-title":"S1P\/S1PR3 axis drives epithelial dysfunction and type 2 inflammation in chronic rhinosinusitis with nasal polyps","author":"Chen","year":"2026","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.ejphar.2026.179343_bib9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.fct.2019.04.037","article-title":"Toxicological and pharmacologic effects of farnesol (C15H26O): a descriptive systematic review","volume":"129","author":"de Ara\u00fajo Delmondes","year":"2019","journal-title":"Food Chem. Toxicol."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179343_bib10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/13543776.2020.1718653","article-title":"Pharmacological applications of farnesol (C15H26O): a patent review","volume":"30","author":"Delmondes","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"issue":"17","key":"10.1016\/j.ejphar.2026.179343_bib11","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1093\/cvr\/cvae239","article-title":"Epitranscriptomic regulation of cardiac fibrosis via YTHDF1-dependent PIEZO2 mRNA m6A modification","volume":"120","author":"Ding","year":"2024","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2026.179343_bib12","series-title":"Comprehensive Physiology","first-page":"1841","article-title":"Pathophysiology of myocardial infarction","author":"Frangogiannis","year":"2015"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179343_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/CIRCRESAHA.119.311148","article-title":"The extracellular matrix in ischemic and nonischemic heart failure","volume":"125","author":"Frangogiannis","year":"2019","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.ejphar.2026.179343_bib14","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","article-title":"Cardiac fibrosis","volume":"117","author":"Frangogiannis","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2026.179343_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yjmcc.2025.08.003","article-title":"Cell type specificity of Hippo-YAP signaling in cardiac development and disease","volume":"207","author":"Guan","year":"2025","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"6","key":"10.1016\/j.ejphar.2026.179343_bib16","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.ccell.2025.04.001","article-title":"Stromal lipid species dictate melanoma metastasis and tropism","volume":"43","author":"Gurung","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejphar.2026.179343_bib17","article-title":"Therapeutic potential of the sphingosine kinase 2 inhibitor opaganib","volume":"4","author":"Huang","year":"2026","journal-title":"Pharm Sci Adv"},{"issue":"3","key":"10.1016\/j.ejphar.2026.179343_bib18","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jacbts.2019.02.006","article-title":"Fibroblasts in the infarcted, remodeling, and failing heart","volume":"4","author":"Humeres","year":"2019","journal-title":"JACC, Basic Transl. Sci."},{"issue":"10","key":"10.1016\/j.ejphar.2026.179343_bib19","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1172\/JCI94753","article-title":"Fibroblast-specific TGF-\u03b2\u2013Smad2\/3 signaling underlies cardiac fibrosis","volume":"127","author":"Khalil","year":"2017","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179343_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/s12915-025-02345-1","article-title":"Uncovering protein prenylation in Th1 cells: novel prenylation sites and insights into statin and farnesyltransferase inhibition","volume":"23","author":"Koch","year":"2025","journal-title":"BMC Biol."},{"issue":"7675","key":"10.1016\/j.ejphar.2026.179343_bib21","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nature24045","article-title":"Hippo pathway deficiency reverses systolic heart failure after infarction","volume":"550","author":"Leach","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179343_bib22","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-018-0860-y","article-title":"Co-stimulation of LPAR1 and S1PR1\/3 increases the transplantation efficacy of human mesenchymal stem cells in drug-induced and alcoholic liver diseases","volume":"9","author":"Li","year":"2018","journal-title":"Stem Cell Res. Ther."},{"issue":"4","key":"10.1016\/j.ejphar.2026.179343_bib23","doi-asserted-by":"crossref","first-page":"H812","DOI":"10.1152\/ajpheart.00335.2017","article-title":"Guidelines for experimental models of myocardial ischemia and infarction","volume":"314","author":"Lindsey","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2026.179343_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.01515","article-title":"The potential of isoprenoids in adjuvant cancer therapy to reduce adverse effects of statins","volume":"9","author":"Mo","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"10513","key":"10.1016\/j.ejphar.2026.179343_bib25","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/S0140-6736(25)01917-8","article-title":"Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990\u20132023: a systematic analysis for the global burden of disease study 2023","volume":"406","author":"Naghavi","year":"2025","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ejphar.2026.179343_bib26","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001412","article-title":"2026 heart disease and stroke statistics: a report of US and global data from the American heart association","volume":"153","author":"Palaniappan","year":"2026","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179343_bib27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","article-title":"The biological basis for cardiac repair after myocardial infarction","volume":"119","author":"Prabhu","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2026.179343_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173583","article-title":"Myocardial hypertrophy is prevented by farnesol through oxidative stress and ERK1\/2 signaling pathways","volume":"887","author":"Souza","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2026.179343_bib29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10557-013-6460-2","article-title":"Cardioprotection by farnesol: role of the mevalonate pathway","volume":"27","author":"Sz\u0171cs","year":"2013","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"26","key":"10.1016\/j.ejphar.2026.179343_bib30","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.ejphar.2026.179343_bib31","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1093\/jimmun\/vkaf103","article-title":"Effect of statins on IL-10 signaling and production by chronic lymphocytic leukemia cells","volume":"214","author":"Wang","year":"2025","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.ejphar.2026.179343_bib32","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/path.5789","article-title":"Cardiac-specific deletion of FDPS induces cardiac remodeling and dysfunction by enhancing the activity of small GTP-binding proteins","volume":"255","author":"Wang","year":"2021","journal-title":"J. Pathol."},{"issue":"7","key":"10.1016\/j.ejphar.2026.179343_bib33","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.7150\/thno.78736","article-title":"Hypoxia induces M2 macrophages to Express VSIG4 and mediate cardiac fibrosis after myocardial infarction","volume":"13","author":"Wang","year":"2023","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.ejphar.2026.179343_bib34","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1093\/cvr\/cvad086","article-title":"Cardiac-specific BACH1 ablation attenuates pathological cardiac hypertrophy by inhibiting the ang II type 1 receptor expression and the Ca2+\/CaMKII pathway","volume":"119","author":"Wei","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2026.179343_bib35","doi-asserted-by":"crossref","DOI":"10.1172\/JCI36693","article-title":"Plasma membrane Ca2+-ATPase isoform 4 antagonizes cardiac hypertrophy in association with calcineurin inhibition in rodents","author":"Wu","year":"2009","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179343_bib36","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1152\/physrev.00065.2017","article-title":"Innate immune signaling and its role in metabolic and cardiovascular diseases","volume":"99","author":"Xu","year":"2019","journal-title":"Physiol. Rev."},{"issue":"11","key":"10.1016\/j.ejphar.2026.179343_bib37","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.7150\/ijbs.107402","article-title":"Activation of sphingosine-1-phosphate receptors can relieve myocardial ischemia-reperfusion injury by mitigating oxidative stress and ferroptosis in cardiomyocytes","volume":"21","author":"Xu","year":"2025","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179343_bib38","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/cvr\/cvs347","article-title":"Cardiac-specific overexpression of farnesyl pyrophosphate synthase induces cardiac hypertrophy and dysfunction in mice","volume":"97","author":"Yang","year":"2013","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179343_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-52068-0","article-title":"Protein kinase N promotes cardiac fibrosis in heart failure by fibroblast-to-myofibroblast conversion","volume":"15","author":"Yoshida","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.179343_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117518","article-title":"Farnesol ameliorates DSS-induced IBD by regulating inflammatory cytokines, repairing the intestinal barrier, reversing the gut microbiota imbalance, and influencing fecal metabolome in C57BL\/6 mice","volume":"180","author":"Yuan","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179343_bib41","doi-asserted-by":"crossref","DOI":"10.1186\/s11658-023-00491-4","article-title":"Macrophage-driven cardiac inflammation and healing: insights from homeostasis and myocardial infarction","volume":"28","author":"Zuo","year":"2023","journal-title":"Cell. Mol. Biol. Lett."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926008253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926008253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:22:19Z","timestamp":1793971339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926008253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":41,"alternative-id":["S0014299926008253"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179343","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Farnesol mitigates post-infarction ventricular remodeling via pharmacological modulation of the SPHK2\/S1P\/SMAD3 axis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179343","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"179343"}}